Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MLXIPL antibody (AA 50-150)

MLXIPL Reactivity: Human, Mouse WB, IF Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN540822
  • Target See all MLXIPL Antibodies
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Binding Specificity
    • 15
    • 14
    • 7
    • 7
    • 6
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 50-150
    Reactivity
    • 44
    • 25
    • 14
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Human, Mouse
    Host
    • 56
    • 3
    Rabbit
    Clonality
    • 56
    • 3
    Polyclonal
    Conjugate
    • 26
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This MLXIPL antibody is un-conjugated
    Application
    • 35
    • 20
    • 20
    • 13
    • 13
    • 10
    • 9
    • 9
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Purpose
    Rabbit polyclonal antibody raised against synthetic peptide of MLXIPL.
    Specificity
    This antibody is specific to ChREBP.
    Cross-Reactivity
    Human, Mouse
    Characteristics
    Antibody Reactive Against Synthetic Peptide.
    Immunogen
    A synthetic peptide corresponding to amino acids 50-150 of human MLXIPL.
    Top Product
    Discover our top product MLXIPL Primary Antibody
  • Application Notes
    Immunofluorescence (1:100-1:500)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.01 % sodium azide)
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C
    Storage Comment
    Store at 4°C. Do not freeze.
  • Iizuka, Bruick, Liang, Horton, Uyeda: "Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 19, pp. 7281-6, (2004) (PubMed).

    Letexier, Pinteur, Large, Fréring, Beylot: "Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue." in: Journal of lipid research, Vol. 44, Issue 11, pp. 2127-34, (2003) (PubMed).

    Yamashita, Takenoshita, Sakurai, Bruick, Henzel, Shillinglaw, Arnot, Uyeda: "A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 16, pp. 9116-21, (2001) (PubMed).

  • Target
    MLXIPL (MLX Interacting Protein-Like (MLXIPL))
    Alternative Name
    MLXIPL (MLXIPL Products)
    Gene ID
    51085
    Pathways
    Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
You are here:
Support